Management of Diverticulitis with IV Antibiotics
Patient Stratification and Antibiotic Selection
- The World Journal of Emergency Surgery recommends piperacillin/tazobactam 4g/0.5g q6h as the first-line treatment for critically ill or immunocompromised patients with adequate source control 1
- For uncomplicated diverticulitis, ciprofloxacin 400mg IV q12h plus metronidazole may be used, particularly in immunocompromised patients 2
- For critically ill or immunocompromised patients with adequate source control, eravacycline 1mg/kg q12h is a recommended option 1
- For patients with inadequate/delayed source control or at high risk of community-acquired ESBL-producing Enterobacterales, ertapenem 1g q24h is a recommended option 1
- For patients with septic shock, meropenem 1g q6h by extended infusion or continuous infusion is a recommended option 1
- For patients with documented beta-lactam allergy, eravacycline 1mg/kg q12h is a recommended option 1
- For patients with documented beta-lactam allergy, tigecycline 100mg loading dose then 50mg q12h is a recommended option 1
Duration of IV Antibiotic Therapy
- The World Journal of Emergency Surgery recommends IV antibiotic therapy for 4 days in immunocompetent and non-critically ill patients with adequate source control 1
- The World Journal of Emergency Surgery recommends IV antibiotic therapy for up to 7 days in immunocompromised or critically ill patients with adequate source control 1
- Patients with ongoing signs of infection beyond 7 days warrant further diagnostic investigation 1
Monitoring Response to Therapy
- The World Journal of Emergency Surgery recommends monitoring white blood cell count, C-reactive protein, and procalcitonin to assess response to treatment 1
- CT imaging remains the gold standard for diagnosis and may be needed to reassess treatment response in patients not improving on current therapy 3